8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): January 13, 2009

PFIZER INC.
(Exact name of registrant as specified in its charter)

Delaware	1-3619	13-5315170
(State or other Jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)
235 East 42nd Street New York, New York (Address of principal executive offices)		10017 (Zip Code)

Registrant's telephone number, including area code:

(212) 573-2323


(Former Name or Former Address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ] Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On January 14, 2009, Pfizer Inc. ("Pfizer") issued a press release announcing the election of Stephen W. Sanger to its Board of Directors, effective February 1, 2009. The information contained in the press release is deemed to be filed under the Securities Exchange Act of 1934 as Exhibit 99 to this report, and such press release is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits
99	Press release of Pfizer Inc. dated January 14, 2009

SIGNATURE

Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.

	PFIZER INC.
	By: /s/  Lawrence A. Fox  Lawrence A. Fox
	Title: Vice President-Corporate Governance, Assistant General Counsel and Assistant Secretary
Dated: January 14, 2009

EXHIBIT INDEX

Exhibit No.	Description
99	Press release of Pfizer Inc. dated January 14, 2009

EX-99

Exhibit 99

For immediate release:	Media Contact:
January 14, 2009	Joan Campion
	(212)733-2798
	Investor Contact:
	Suzanne Harnett
	(212) 733-8009

STEPHEN W. SANGER ELECTED TO PFIZER'S BOARD OF DIRECTORS

NEW YORK, NY, January 14 - Pfizer Inc today announced the election of Stephen W. Sanger to its Board of Directors, effective February 1, 2009.

Mr. Sanger, 62, served as the Chairman of General Mills, Inc. from 1995 until his retirement in 2008. He joined General Mills in 1974 and held a variety of positions with increasing responsibility in marketing management across the company's consumer food businesses. He was elected to General Mills' Board of Directors in 1992, named President of General Mills in 1993, and served as the Chief Executive Officer from 1995 until 2007. He began his career at Procter & Gamble in 1970.

Mr. Sanger is currently a director of Target Corporation and Wells Fargo & Company, and a member of the board of the Guthrie Theater in Minneapolis, Minnesota. In addition, Mr. Sanger is a member of the Business Council and the U.S. Advisory Committee for Trade Policy and Negotiations.

Mr. Sanger earned a bachelor's degree in history from DePauw University and an MBA from the University of Michigan.

# # # # #